Merilyn Hibma
Merilyn Hibma | |
|---|---|
| Academic background | |
| Theses |
|
| Academic work | |
| Institutions | University of Otago |
Merilyn Hibma is a New Zealand viral immunologist, and is a full professor at the University of Otago, specialising in immune regulation by viruses, especially human papillomavirus, the causative agent of cervical cancer.
Academic career
[edit]Hibma completed Master of Science in microbiology at Otago,[1] followed by a PhD titled Humoral immunity in farmed deer also at Otago in 1989.[2] Hibma completed her postdoctoral research at the University of Cambridge, working with Lionel Crawford at the Imperial Cancer Research Fund laboratory.[3][4] Hibma was awarded a Health Research Council Repatriation Fellowship, which allowed her to return to take up a faculty position in the Department of Microbiology and Immunology at the University of Otago.[4] Hibma transferred to the Department of Pathology in 2014, the same year she was appointed research associate professor. She was promoted to full professor in 2021.[3][5][4] Hibma is an associate researcher in the Maurice Wilkins Centre for Molecular Biodiscovery.[6]
Hibma's research focuses on immune regulation by viruses, and she has a particular interest in human papillomavirus, the causative agent of cervical cancer.[4] Hibma's team identified a viral protein, named E7, that appeared to be responsible for suppressing the immune response to the virus. The presence of this protein in patients was correlated with the later development of cervical cancer.[7][8][9] Hibma works on understanding the biology of human papillomavirus, as well as the development of new immunotherapeutics.[4]
Hibma has led efforts to get effective screening and treatment programmes for cervical cancer in the Pacific.[10][11]
Selected works
[edit]
- Kate Middleton; Woei Peh; Shirley Southern; et al. (1 October 2003). "Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers". Journal of Virology. 77 (19): 10186–10201. doi:10.1128/JVI.77.19.10186-10201.2003. ISSN 0022-538X. PMC 228472. PMID 12970404. Wikidata Q36524778.
- Kate Matthews; Cheng Mee Leong; Lindsay Baxter; Emma Inglis; Kankatsu Yun; B Thomas Bäckström; John Doorbar; Merilyn Hibma (1 August 2003). "Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin". Journal of Virology. 77 (15): 8378–8385. doi:10.1128/JVI.77.15.8378-8385.2003. ISSN 0022-538X. PMC 165258. PMID 12857907. Wikidata Q35155315.
- Sara J. Edwards; Brett R Dix; Colleen J Myers; Deirdre Dobson-Le; Lily Huschtscha; Merilyn Hibma; Janice Royds; Antony W Braithwaite (1 December 2002). "Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes". Journal of Virology. 76 (24): 12483–12490. doi:10.1128/JVI.76.24.12483-12490.2002. ISSN 0022-538X. PMC 136704. PMID 12438574. Wikidata Q39685569.
- J Dillner; F Wiklund; P Lenner; et al. (1 January 1995). "Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer". International Journal of Cancer. 60 (3): 377–382. doi:10.1002/IJC.2910600318. ISSN 0020-7136. PMID 7530234. Wikidata Q71669731.
- Royds JA; Hibma M; Dix BR; Hananeia L; Russell IA; Wiles A; Wynford-Thomas D; Braithwaite AW (1 March 2006). "p53 promotes adenoviral replication and increases late viral gene expression". Oncogene. 25 (10): 1509–1520. doi:10.1038/SJ.ONC.1209185. ISSN 0950-9232. PMID 16247442. Wikidata Q40358341.
- Stephanie Dillon; Toshiyuki Sasagawa; Anna Crawford; Jan Prestidge; Marie K Inder; Jim Jerram; Andy Mercer; Merilyn Hibma (1 March 2007). "Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2". Journal of General Virology. 88 (Pt 3): 803–813. doi:10.1099/VIR.0.82678-0. ISSN 0022-1317. PMID 17325352. Wikidata Q45128963.
References
[edit]- ^ Hibma, Merilyn (1986). Humoral immunity in pregnancy : a guinea pig model (MSc thesis). University of Otago.
- ^ Hibma, Merilyn (1989). Humoral immunity in farmed deer (PhD thesis). University of Otago.
- ^ a b Board, Otago Bulletin (8 December 2020). "Otago announces 26 new professors". www.otago.ac.nz. Retrieved 17 February 2024.
- ^ a b c d e University of Otago (4 August 2023). "Professor Merilyn Hibma: Profile". www.otago.ac.nz. Retrieved 17 February 2024.
- ^ Gibb, John (2 January 2014). "12 staff to become professors". Otago Daily Times Online News. Retrieved 17 February 2024.
- ^ "Associate Investigators | Maurice Wilkins Centre". www.mauricewilkinscentre.org. Retrieved 17 February 2024.
- ^ "Prof Merilyn Hibma: Researchers inch closer to new treatment for cervical cancer". Newstalk ZB. 17 February 2024. Retrieved 17 February 2024.
- ^ Simon Collins (17 February 2024). "First step to new cervical cancer drug". The New Zealand Herald. Retrieved 17 February 2024.
- ^ Taylor, Margot (12 October 2016). "Papillomavirus better understood". Otago Daily Times Online News. Retrieved 17 February 2024.
- ^ Houlahan, Mike (5 June 2018). "Cancer screening initiatives in the Pacific". Otago Daily Times Online News. Retrieved 17 February 2024.
- ^ "Cervical screening programme push in Samoa". RNZ. 4 June 2018. Retrieved 17 February 2024.
External links
[edit]- Merilyn Hibma's inaugural professorial lecture, 28 September 2022, via YouTube
| Authority control databases: Academics |
|---|
